Dongguan, China

Xinye Yang

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Xinye Yang: Innovator and Patents Contributor from Dongguan, China

Introduction:

Meet Xinye Yang, a talented innovator hailing from Dongguan, China. With a sharp mind and an inherent passion for research and development, Yang has made significant contributions to the field of medicine through his groundbreaking patents. This article explores Yang's latest patents, highlights of his career, notable collaborations, and his ongoing commitment to innovation.

Latest Patents:

As a prolific inventor, Xinye Yang has secured a total of five patents, each reflecting his expertise and dedication to advancing medical science. Let's delve into his two most recent patents:

1. Nitrogenous Tricyclic Compounds and Uses Thereof in Medicine:

In this patent, Yang introduces a novel nitrogenous tricyclic compound that acts as an FXR (Farnesoid X receptor) active regulator. The compound, along with its various isomers, metabolites, and salts, demonstrates promise in treating diseases and disorders regulated by FXR. This patent sheds light on potential therapeutic avenues for conditions dependent on the FXR pathway.

2. Thienopyrimidine Derivative and Use Thereof in Medicine:

Yang's second patent highlights a thienopyrimidine derivative that inhibits acetyl-CoA carboxylase (ACC). This compound, along with its pharmaceutical composition, showcases potential applications for the treatment and prevention of diseases regulated by ACC in mammals, particularly in humans. It represents a significant stride towards developing targeted therapeutics against ACC-mediated disorders.

Career Highlights:

Throughout his career, Xinye Yang has showcased his brilliance by making a meaningful impact on the medical field. While his patents speak volumes about his contributions, it's worth noting that Yang has worked with reputable organizations to further his research and development endeavors. Two notable companies he has been associated with are:

1. Sunshine Lake Pharma Co., Ltd.:

With its focus on pharmaceutical research and development, Sunshine Lake Pharma Co., Ltd. provided Yang with an ideal platform to explore innovative medical solutions. Collaborating with experts in the field, Yang undoubtedly made valuable contributions during his tenure at this esteemed organization.

2. North & South Brother Pharmacy Investment Company Limited:

This notable pharmaceutical investment company provided Yang with a unique opportunity to explore the intersection of medicine and business. While contributing to the company's vision, Yang further honed his skills and expanded his network within the industry.

Collaborations:

Alongside his professional engagements, Xinye Yang has had the privilege of working alongside accomplished individuals who share his passion and drive for innovation. Notable coworkers who have collaborated with Yang on his patents include Xiaojun Wang and Yingjun Zhang. These collaborations have undoubtedly fostered a rich exchange of ideas and expertise, leading to further advancements in the medical field.

Conclusion:

Xinye Yang's impressive track record of patents and career highlights demonstrates his unwavering commitment to innovation in medicine. Through his inventions, he has opened new avenues for treating diseases and disorders regulated by FXR and ACC. Yang's collaborations with esteemed organizations and coworkers showcase his ability to thrive in diverse environments, leveraging collective knowledge to fuel groundbreaking advancements.

As Xinye Yang continues his journey as an innovator, we look forward to witnessing his future contributions and the positive impact they will undoubtedly have on the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…